List view / Grid view
Drug Discovery Processes
23 May 2019 | By Sartorius
Immunotherapy for cancers involves artificially prompting the immune system to treat cancer. Many cancer cells have surface tumour antigen molecules, which can be detected by the immune system’s antibody proteins, which bind to the antigen.
1 May 2019 | By Taconic Biosciences
Ensure reproducibility with TruBIOME™ - the unique approach to generating research model colonies, which allows you complete control over their microbiome, from conception to cohort delivery.
25 April 2019 | By ThermoFisher Scientific
High-content analysis: monitoring neurite morphology and synapse formation in primary neurons for neurotoxicity assessments and drug screening.
26 March 2019 | By Thermo Fisher Scientfic
Dr Kaylene Simpson, Peter MacCallum Cancer Center, describes their research using high content imaging to examine RNA in cancer cells.
21 March 2019 | By NanoTemper Technologies
Current technologies that measure molecular interactions for drug discovery slow down and complicate screening. Dianthus is the answer to the demands for fast, non-stop, highly sensitive hit identification, hit validation and lead optimisation.
20 March 2019 | By Jeff Martin (Head of Compound Management - Alkermes Inc.)
Data drives drug discovery, yet it continues to be among the biggest challenges faced by the industry.1 Experiments are often not repeatable and data interpretation is subject to the biases and limitations of human beings.
Cell line development – global market drivers, trends and its impact on improving biologics development from early phase to IND during the drug discovery process
19 March 2019 | By Aparajita Dubey - Associate Consultant at Prescient Healthcare Group
Cell line development is a major step for examining the efficiency of drug discovery, toxicity and in vitro testing. It reduces time, effort and cost, which minimises the chance of research drugs failing at the clinical trial stage. This stage involves the production of recombinant proteins such as monoclonal antibodies,…
18 February 2019 | By Tecan and Ncardia
Ncardia, will discuss the application of human iPSC-derived cell-based assays and high throughput screening for drug discovery and development.
13 February 2019 | By Iqra Farooq (Drug Target Review)
Hydrogels could be used to build organs on chips to test potential medications, with the aim that they could potentially replace animal studies...